trastuzumabe engTRASTUZUMAB
Presentation: Vial-ampoule with lyophilized powder for solution for injection, 150 mg.
Used for the treatment of HER2+ breast cancer.

 

rituximabe engRITUXIMAB
Presentation: 100 and 500 mg injectables (via vials of 10mL and 50mL).
Used for the treatment of non-hodgkin lymphoma and Chronic lymphocytic leukemia.

 

 

Back